Completing data — refresh the page later to see the latest
1265917-14-3Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1.ClSHRYQZBTQDMGLZ-UHFFFAOYSA-N1265917-14-3CHEMBL6166506Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionS1RA (E-52862, 1265917-14-3) is a potent and selective σ1 antagonist with weak binding at σ2(IC50σ1 = 17nM, σ2 = 9300nM).1,2S1RA abolished mechanical and thermal hyperalgesia in mice with carrageenan-induced acute inflammation by enhancing the action of endogenous opioid peptides of immune origin in a σ1 dependent manner.3S1RA potentiated μ-opioid antinociception in mice in a σ-dependent manner.4S1RA displayed neuroprotective effects in a mouse model of ischemic stroke.5
UsesS1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (σ1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against σ2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 μM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization[1][2].